Home › NDC Lookup › RxCUI directory › RxCUI 597850

Anagrelide 0.5 MG Oral Capsule — RxCUI 597850

RxNorm drug concept · Semantic clinical drug
RxCUI 597850 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI597850
Official nameAnagrelide 0.5 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asanagrelide 0.5 MG (as anagrelide HCl) Oral Capsule; anagrelide HCl 0.5 MG Oral Capsule
FDA products mapped5
Package NDCs mapped7
Reported Medicaid activity (SDUD)1,137 prescriptions · 13 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Anagrelide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Anagrelide is bringing down a platelet count that's dangerously high because of a bone marrow disorder. When you have too many platelets, your blood can form clots too easily — whi...
  • What exactly is this medication doing for me?
  • You can take anagrelide capsules with or without food — there's no strict requirement. Food does slow down how quickly the medication is absorbed, but it doesn't meaningfully chang...
  • Can I take this with food, or does it need to be on an empty stomach?
📖 Read our full Anagrelide guide →

🕸️ Concept Web — How Anagrelide 0.5 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Anagrelide 0.5 MG Oral Capsule RxCUI 597850

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Anagrelide 596724
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Agrylin 215060
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Anagrelide Oral Capsule 597849
    • Anagrelide Oral Product 1157699
    • Anagrelide Pill 1157700
    • Anagrelide Oral Capsule [Agrylin] 597854
    • Agrylin Oral Product 1172793
    • Agrylin Pill 1172794
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Anagrelide 0.5 MG SCDC · 597848
  • Anagrelide Oral Capsule SCDF · 597849
  • Anagrelide Oral Product SCDG · 1157699
  • Anagrelide Pill SCDG · 1157700

Brand-Name Concepts

  • Anagrelide 0.5 MG Oral Capsule [Agrylin] SBD · 597857
  • Anagrelide 0.5 MG [Agrylin] SBDC · 597856
  • Anagrelide Oral Capsule [Agrylin] SBDF · 597854
  • Agrylin Oral Product SBDG · 1172793
  • Agrylin Pill SBDG · 1172794
  • Agrylin BN · 215060

📦 FDA Products & Package NDCs

5 products · 7 package NDCs
7 package NDCs map to RxCUI 597850 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
13668-0453-01 100 CAPSULE in 1 BOTTLE (13668-453-01) anagrelide Torrent Pharmaceuticals Limited 2017-06-30
13668-0453-30 30 CAPSULE in 1 BOTTLE (13668-453-30) anagrelide Torrent Pharmaceuticals Limited 2017-06-30
13668-0462-01 100 CAPSULE in 1 BOTTLE (13668-462-01) anagrelide Torrent Pharmaceuticals Limited 2017-06-30
13668-0462-30 30 CAPSULE in 1 BOTTLE (13668-462-30) anagrelide Torrent Pharmaceuticals Limited 2017-06-30
54092-0063-01 100 CAPSULE in 1 BOTTLE (54092-063-01) Agrylin Takeda Pharmaceuticals America, Inc. 1997-03-14
62135-0312-12 120 CAPSULE in 1 BOTTLE (62135-312-12) Anagrelide Chartwell RX, LLC 2024-02-05
62135-0313-60 60 CAPSULE in 1 BOTTLE (62135-313-60) Anagrelide Chartwell RX, LLC 2024-02-05
Observed labelers: Torrent Pharmaceuticals Limited (4) · Chartwell RX, LLC (2) · Takeda Pharmaceuticals America, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.